Atlas Trials

Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism

Clinical trial NCT06264544 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06264544
Sponsor
S.LAB (SOLOWAYS)
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Thyrotoxicosis
Start date
2025-07-30
Primary completion
2025-10-15
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.